Home: Research Projects: Techniques for Molecular Imaging

Techniques for Molecular Imaging

Project Leader

Zhonglin Liu, M.D.

Project Summary

The overall objective of Core Project V is to translate the advances in biomedical imaging developed in the other Core Projects into specific investigations of important biomedical topics. To do so, we will apply SPECT imaging techniques in small-animal models for basic investigations in cardiology, oncology, and neurology. Investigations will emphasize quantitative dynamic imaging. These methods will serve as a test bed for the other Core Projects, and they will also provide a platform for collaborative research and ultimately for clinical translation.

Current Projects

Implement and validate small-animal models of ischemia-reperfusion injury and use selected radiotracers to detect and quantify the injury and its development.

  • Myocardial perfusion imaging in rat/mouse heart models.

  • Detection of myocardial necrosis and apoptosis in rat hearts with ischemia-reperfusion injury.

  • Inflammation imaging in rat hearts with ischemia-reperfusion injury.

Determine the effects of cardioprotective strategies using the imaging methods and small-animal models.

  • Imaging study of protective role of ischemic preconditioning in rat hearts with ischemia-reperfusion.

  • Investigation of the short-term and long-term cardioprotective effects of melatonin (N-acetyl-5-methoxytryptamine) in ischemia-reperfused rat hearts with using noninvasive SPECT imaging.

  • Assessment of the cardioprotective effects of different anesthetic agents using rat heart models and SPECT imaging.

  • In vivo tracking of transplanted rat Mesenchymal Stem Cells (MSCs) by SPECT imaging.

Explore the tumor-targeting properties of novel-imaging agents in animal models of human cancer and characterize the properties of these agents for evaluating tumor response to chemotherapy.

  • 99mTc-glucarate imaging of xenografted human breast cancer and lung cancer.

  • Tumor targeting using 99mTc-labeled vasoactive intestinal peptide (VIP).

  • Investigation of tumor glucose metabolism using 99mTc-ethylenedicysteineglucosamine (ECDG).

  • Characterization of radiolabeled bi-specific ligands targeting tumor growth factors.

  • Evaluation of tumor response to chemotherapy using radiolabeled biomarkers for apoptosis.

Click here for an overview of some animal imaging research.

Animal Imaging Studies at the CGRI

 

Study

Tracer

Imaging Systems

Collaborators

Animals Imaged to date

Status as of March 2008

Myocardial infarct detection

99mTc-sestamibi

FastSPECT

___

20

Done

Recognition of multi-drug ressitance in breast-cancer xenografts
99mTc-sestamibi, tetrofosmin, Q12
FastSPECT
GE Healthcare(Amersham); Bracco Diagnostics, Inc.
42
Done
Drug-sensitive and resistant breast-cancer xenografts
99mTc-glucarate
FastSPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
35
Done
Ischemia-reperfusion injusry in rat heart model
99mTc-glucarate
FastSPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
18
Done
Inhibition of mutli-drug resistance (breast cancer)
99mTc-sestamibi, tetrofosmin, Q12
FastSPECT
GE Healthcare(Amersham)
50
Done
Targeting of viral agents to tumors
99mTc-labeled somatostain receptor ligand
FastSPECT
K. R. Zinn, University of Alabama at Birmingham
12
Done
Ischemic preconditioning in rat hearts
99mTc-glucarate
FastSPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
18
Done
Sequential rat-heart imaging
9mTc-teboroxime and 99mTc-glucarate
FastSPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
15
Done
Inhibition of multidrug resistance
99mTc-Q12
FastSPECT
Bracco Diagnostics, Inc.
26
Done
Cardioprotection: preconditioning effects of adenosine
99mTc-glucarate
FastSPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
28
Done
Human lung-cancer xenografts
99mTc-glucarate

SemiSPECT

FastSPECT

Koon Y. Pak, Molecular Targetting Technologies, Inc.
23
Done
Response of breast-cancer xenografts to chemotherapy
99mTc-glucarate
FastSPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
41
Done
Cardioprotection: effects of antioxidants
99mTc-tetrofosmin
FastSPECT II
___
30
Done
Induced lung adenomas in mice
99mTc-sestamibi, glucarate, depreotide
Dual Modality CT/SPECT
Paul Myrdal, UA College of Pharmacy
12
Ongoing
Sodium iodide symporter expression
99mTc-pertechnetate
FastSPECT
Frederick Domann, Univeristy of Iowa
4
Plan to do more
Induction of apoptosis
99mTc-annexin V
FastSPECT
Alison Stopeck, UA Cancer center
4
Done
Cardioprotection: effects of cyclosporine - A
99mTc-glucarate
FastSPECT
Douglas Larson, UA Dept. of surgery; Koon Y. Pak, Molecular Targetting Technologies, Inc.
9
Done
Myocardial infarction in mouse heart model
99mTc-tetrofosmin, glucarate
SemiSPECT and FastSPECT II
Koon Y. Pak, Molecular Targetting Technologies, Inc.
11
Ongoing
Neuroblastoma bone metastases
99mTc-MDP
Dual Modality CT/SPECT
Rex Moats, Children's Hospital(Los Angeles)
6
Done
Cardioprotection:anesthetic agents
99mTc-tetrofosmin, glucarate
FastSPECT II
Peter Lichtenthal, UA Dept. of Surgery
51
Done
Lymphedema in mouse models
99mTc-sulphur colloid
Dual Modality CT/SPECT
Marlys Witte, UA Dept of Surgery
8
Done: may plan to do mor
Detection of cardiotoxicty
99mTc-sestamibi
FastSPECT and FastSPECT II
___
25
Done
Rat hearts with ischemia-reperfusion injury
99mTc-tetrofosmin
FastSPECT II
___
11
Done
Imaging comparison of lung and breast tumors
99mTc-sestamibi
FastSPECT
___
13
Done
Imaging mouse femora attached by strain guages
99mTc-MDP
Dual Modality CT/SPECT
David Margolis, UA Dept. of Orthopedic Surgery
6
Done
Mouse bone imaging
X-ray
CT
Lihua Marmorstein, UA Dept. of Ophthalmology
8
Done
Detection of bone metasis in mice
99mTc-MDP
Dual Modality CT/SPECT
Bethany Skovan, UA Cancer Center
8
Done
Apoptosis imaging in rat hearts
99mTc-C2A-GST
FastSPECT II
Ming Zhao, Medical college of Wisconsin
8
Done
Mechanism of Glucarate uptake in tumors
99mTc-glucarate
FastSPECT, Dual Modality CT/SPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
24
Done

Tumor targetting of 99mTc-VIP

99mTc-VIP-Taxol
FastSPECT II, Dual Modality CT/SPECT
Koon Y. Pak, Molecular Targetting Technologies, Inc.
6
Plan to do more
Apoptosis imaging in tumors
99mTc-C2A-GST
FastSPECT II, Dual Modality CT/SPECT
Ming Zhao, Medical college of Wisconsin
6
Done
Myocardial perfusion imaging in rats
99mTc-15C5PNP
FastSPECT
Shuang Liu, Purdue University
20
Done
Inflammation imaging in rats and mice
99mTc-IL-18bp-Fc-IL-1ra
FastSPECT and FastSPECT II

Mathew H. Hui, AmProtein Corporation

49
Done
Tracking mesenchymal stem cells

111In-oxine 99mTc-sestamibi

FastSPECT II
Frank Barry University of Ireland
14
Plan to do more
Imaging tumors in mouse dorsal skin-fold chamber

18F-FDG

Electrons Imager
___
10
Plan to do more
Dynamic SPECT imaging of mouse and rat lung
99mTc-MAA
Dual Modality CT/SPECT
Anne Clough, Davif Reorig, Marqutee University
0
Planned
Imaging brain in rats
99mTc-HMPAO
FastSPECT II
___
5
Plan to do more
Inflammation imaging in rats and mice
99mTc-TNFR2-Fc-IL-1ra
FastSPECT and FastSPECT II

Mathew H. Hui, AmProtein Corporation

11
Ongoing
Inflammation imaging in rats and mice
99mTc-IL-1ra-Fc
FastSPECT and FastSPECT II

Mathew H. Hui, AmProtein Corporation

8
Ongoing
Cardioprotection of TNFR2-Fc-IL-1ra in rats
99mTc-sestamibi
FastSPECT II

Mathew H. Hui, AmProtein Corporation

14
Plan to do more
Tumor targetting of 99mTc-IL-18bp-Fc-IL-1ra in mice
99mTc-IL-18bp-Fc-IL-1ra
FastSPECT II

Mathew H. Hui, AmProtein Corporation

17
Ongoing
Imaging bone metastasis in mice
99mTc-MDP
Dual Modality CT/SPECT
Anne Cress, UA Cancer Center
7
Done
Tumor glucose uptake
99mTc-ECDG
Dual Modality CT/SPECT, Electrons Imager
Negar Knowles, UA, Dept. of Radiology
4
Plan to do more

 

 

Successive 1 mm coronal slices of FastSPECT II images of apoptosis in the infarcted region of a heart.  The tracer was the C2A domain of synaptotagmin  labelled with 99mTc.  Significant uptake is seen in liver but almost none in normal heart

 

1 mm sagittal slices of 111In –oxine labeled MSCs 48 hrs after intracoronary injection

 

Illustrations of the dorsal window chamber

 

Dynamic image sequence showing the positron emission from FDG from an implanted breast tumor in the window chamber.  Exposure time of 2 minutes per image

SPECT imaging of ischemia-reperfused hearts

Left panel: 99mTc-C2A dynamic images in a rat heart with ischemia-reperfusion. Cardiac blood pool is evident on the 1-min image (top left). A hot spot in the left ventricular wall was achieved 10-30 minutes post-injection. The arrow at 120-min indicates the site of the infarct (bottom right). Right panel: 99mTc-C2A time-activity curves from infarcted myocardium, viable zone, and lungs.

 

99mTc-labeled TNFR2-Fc-IL-1ra images 3 hours post-injection in two ischemic and reperfused rat hearts, showing radioactive “hot spots” in the ischemic area.

 

99mTc-TNFR2-Fc-IL-1ra dynamic images. Times in minutes are at lower right of each frame. Uptake is evident in infarcted myocardium and in the liver.

 

FastSPECT II MIBI images (transverse slices, 1 mm per slice) from a control (left panel) and DOX-treated rat heart (right panel) 2 hours post-injection. Reduced left ventricular wall thickness and inhomogeneous radiotracer distribution were found in the DOX-treated heart.

SPECT imaging of atherosclerosis and vascular restenosis

99mTc-IL-18bp-Fc-IL-1ra SPECT images of carotid arteries 3 hours post-injection. Increased radioactive uptake was observed in the injured side

 

Tracking 111In-MSCs-GFP after IV injection. Left panel: SPECT images (three transverse slices, 1 mm) show high activity in the lungs at 1 hr post-injection, but not in the heart. Lung activity disappeared 5 days later and activity in the heart (arrow) became detectable. Right panel: Tissue autoradiograph (AR) in selected 10 mm and 10 μm slice shows activity in the ischemic area; microscopic (MS) image shows GFP green light signals (bright white spots on the picture) from where radioactivity accumulated.

Tumor imaging

Tumor chamber and dynamic imaging of HCT116 tumor using 18F-FDG and  electron imager.

 

FastSPECT images (coronal slices, 1 mm perslice) show high uptake (dashed mark) of 99mTc-labeled polypeptide in a peritoneal tumor seeding model with human ovarian cancer.

 

99mTc-IL-18bp-Fc-IL-1ra images in HCT116 cancer. Increasing tracer uptake (dashed marks) was shown up to 24 hours post-injection.

Neuro imaging

TTC staining of brain slices from a rat MCAO model (90-minute ischemia followed by 5-hour reperfusion), demonstrating infarctions (TTC-unstained areas) in the left hemisphere.

 

Home: Research Projects: Techniques for Molecular Imaging

 



NIBIB

Center for Gamma-Ray Imaging
The University of Arizona

October 2008
© 2008 Arizona Board of Regents